Skip to main content
SpringerLink
Log in

Guidelines for the Prevention of Sudden Cardiac Death: Filling the Gap

  • Conference paper
Emerging Pathologies in Cardiology

Conclusions

Evidence-based large clinical trials have undoubtedly demonstrated the benefits of ICD in specific populations. Guidelines are intended only as a tool to aid in the decision whether to implant an ICD or CRT device. The responsibility of physicians is primarily towards their patients, but judicious use of health care resources is critical to be able to provide a fair share to all the patients in need of these devices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tang AS, Ross H, Simpson C et al (2005) Canadian Cardiovascular Society/Canadian Heart Rhythm Society. Position paper on implantable cardioverter defibrillator (ICD) use in Canada. Can J Cardiol (in press)

    Google Scholar 

  2. Josephson M, Wellens HJJ (2004) Implantable defibrillators and sudden cardiac death. Circulation 109:2685–2691

    Article  PubMed  Google Scholar 

  3. American Heart Association (2001) 2002 Heart and stroke statistical update.American Heart Association, Dallas, Texas

    Google Scholar 

  4. Vreede-Swagemakers JJM, Gorgels APM, Dubois-Arbouw WI et al (1997) Out-of-hospital cardiac arrest in the 1900s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30:1500–1505

    Article  PubMed  Google Scholar 

  5. Gregoratos G, Abrams J, Epstein AE et al (2002) ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 106:2145–2161

    Article  PubMed  Google Scholar 

  6. Moss AJ, Hall WJ, Cannom DS et al (1996) Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940

    Article  PubMed  CAS  Google Scholar 

  7. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  8. Buxton AE, Lee KL, Fisher JD et al (1999) Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890

    Article  PubMed  CAS  Google Scholar 

  9. Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. DINAMIT investigators. N Engl J Med 351:2481–2488

    Article  PubMed  CAS  Google Scholar 

  10. Bansch D, Antz M, Boczor S et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT). Circulation 105:1453–1458

    Article  PubMed  Google Scholar 

  11. Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia — AMIOVIRT. J Am Coll Cardiol 41:1707–1712

    Article  PubMed  Google Scholar 

  12. Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158

    Article  PubMed  CAS  Google Scholar 

  13. The sudden cardiac death in heart failure trial (SCD-HeFT): http://www.sicr.org/scdheft

    Google Scholar 

  14. Klein H, Auricchio A, Reek S et al (1999) New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HeFT and MADITII. Am J Cardiol 83:91D–97D

    Article  PubMed  CAS  Google Scholar 

  15. Englestein ED (2003) Prevention and management of chronic heart failure with electrical therapy. AJC 91:62F–73F

    Google Scholar 

  16. Desai AS, Fang JC, Maisel WH et al (2004) Implantable defibrillators for the prevention of mortality in patients with nonischemic cadiomyopathy: a meta-analysis of randomized controlled trial. J Am Med Assoc 292:2873–2879

    Article  Google Scholar 

  17. Connolly SJ, Gent M, Robert RS et al (2000) Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302

    PubMed  CAS  Google Scholar 

  18. Kuck KH, Cappato R, Siebels J et al (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754

    PubMed  CAS  Google Scholar 

  19. Anderson JL, Hallstrom AP, Epstein AE et al, for the AVID Investigators (1999) Design and results of the Antiarrhythmic Vs. Implantable Defibrillators (AVID) registry. Circulation 99:1692–1699

    PubMed  CAS  Google Scholar 

  20. Connolly SJ, Hallstrom AP, Cappato R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmic vs. implantable defibrillator study. Eur Heart J 21:2071–2078

    Article  PubMed  CAS  Google Scholar 

  21. Priori SG, Aliot E, Blomstrom-Lundqvist C et al (2002) Task force on sudden death, European Society of Cardiology. Summary of recommendations. Europace 4:3–18

    Article  PubMed  CAS  Google Scholar 

  22. Priori SG, Aliot E, Blomstrom-Lundqvist C et al (2003) Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 24:13–15

    Article  PubMed  Google Scholar 

  23. Brugada J, Brugada R, Brugada P (1998) Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 97:457–460

    PubMed  CAS  Google Scholar 

  24. Priori SG, Napolitano C, Gasparini M et al (2000) Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102:2509–2515

    PubMed  CAS  Google Scholar 

  25. Priori SG, Napolitano C, Bloise R et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874

    Article  PubMed  Google Scholar 

  26. Link MS, Wang PJ, Haugh CJ et al (1997) Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1:41–48

    Article  PubMed  CAS  Google Scholar 

  27. Leenhardt A, Lucet V, Denjoy I et al (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91:1512–1519

    PubMed  CAS  Google Scholar 

  28. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  PubMed  CAS  Google Scholar 

  29. Morillo CA (2004) A prophylactic cardioverter-defibrillator prevented sudden death from arrhythmia in nonischemic cardiomyopathy. ACP J Club 141(3):61

    PubMed  Google Scholar 

  30. Morillo CA (2004) Cardiac resynchronization therapy reduced all-cause death and hospitalization in chronic heart failure. ACP J Club 141(3):60

    PubMed  Google Scholar 

  31. Priori SG, Klein W (2003) Medical practice guidelines. Separating science from economics. Eur Heart J 24:1962–1964

    Article  PubMed  Google Scholar 

  32. Chen L, Hay JW (2004) Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure. Cardiovasc Drug Ther 18:161–170

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Arrhythmia Service, McMaster University, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada

    A. Baranchuk & C. Morillo

Authors
  1. A. Baranchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Morillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiology Division, S. Luigi — S.Currò Hospital, Catania, Italy

    M. M. Gulizia MD (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this paper

Cite this paper

Baranchuk, A., Morillo, C. (2005). Guidelines for the Prevention of Sudden Cardiac Death: Filling the Gap. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_26

Download citation

  • DOI: https://doi.org/10.1007/88-470-0341-5_26

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0311-8

  • Online ISBN: 978-88-470-0341-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation